Schedule & Agenda

World-class education program, delivered in person in San Diego, CA

BIO International Convention
Date
  • Show All
Time
  • Show All
  • Show All
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO International Convention
Jump to Day
98 Results
Monday, June 13
1:00 PM - 2:00 PM (PDT)
What do biotech companies need to consider as they develop the next breakthrough treatment for…
When Vividion examined the next steps for their company, an IPO was the path forward. Until one day…
Pre-POC biotechs, including platform companies, are increasingly recognizing the importance of…
In late 2020, FDA announced that it had awarded four grants to researchers to examine the use of…
The biotechnology industry touches every part of our lives, from the medicines helping patients,…
In the Business Development and Transactions community, we often focus on the big splashy asset or …
Conducting a successful clinical trial for orphan and rare diseases presents unique challenges…
Learn how different organizations are approaching using AI/ML, their thoughts on the challenges and…
2:15 PM - 3:15 PM (PDT)
In March 2022, the Biopharma Sustainability Roundtable (BRST) published an expanded resource for…
With the delivery of mRNA-based COVID-19 vaccines, mRNA earned its rightful place among the leading…
Individualized antisense oligonucleotide (ASO) technology is increasingly capturing the attention…
ORBIS has demonstrated success and seems to function as a forum for other global regulators to…
Regulatory guidance to support submission of high validity and relevance of real-world evidence …
A key question facing pre-commercial emerging pharma and biotech company leadership and directors…
While COVID-19 only first emerged in 2019, influenza has been plaguing humanity for centuries…
3:30 PM - 4:30 PM (PDT)
Global health inequity has many dimensions, and strategies are needed to address each of these…
As we begin to enter an endemic phase of COVID-19, we are reflecting on the triumphs, challenges…
Tuesday, June 14
11:00 AM - 12:00 PM (PDT)
 Although specific aspects of clinical trials decentralization were in place before the…
Our nation’s newborn screening system is a public health success but increasingly lags far…
Life sciences and healthcare companies are leveraging machine learning and AI for new advancements…
As several new therapies originating in China begin reaching the review and regulatory approval…
Recent collaborations and financing deals involving small-mid biotechs and big pharmaceutical firms…
Genomic medicines continues to move to the forefront with an expected growth to $95B in 2028 (from …
Patient advocacy organizations (PAOs) are increasingly offering sophisticated resources and…
Aging is the primary risk factor for many chronic conditions, and diseases of aging represent an…
The COVID-19 pandemic has been a catalyst for vaccine innovation, with both the development of…
Emerging biotechs applying today’s revolutionary technologies face two interrelated questions…
1:45 PM - 2:45 PM (PDT)
The rare disease patient undergoes a diagnostic odyssey that takes five to eight years on average,…
Diagnostics and research tools are informing novel vaccine development like the COVID mRNA vaccines…
Enhancing diversity and inclusion in clinical studies is critical to closing the health equity gap…
Hemostasis and thrombosis are believed to be so intricately linked that any strategies that reduce…
Strategic partnerships are critical for driving digital health innovation forward. Join us for an…
2020 was the year of the SPAC – raising nearly double what was raised over the course of the…
Given a less than 8% likelihood for a New Drug Approval from first in man clinical trials, drug…
1:45 PM - 3:00 PM (PDT)
The current pandemic has created a national discussion about the fragility of global supply chains…
3:00 PM - 4:00 PM (PDT)
Over the course of the COVID-19 pandemic, vaccine developers worked with manufacturing partners…
Partnerships between pharma and biotech hit record levels in 2021 both in terms of deals volume and…
While chronic diseases often pose persistent, daily challenges, many patients have few treatment…
Join us for an interactive roundtable discussion with the leaders of The Center for Drug Evaluation…
The challenge of health equity is common across healthcare systems, but it will require different…
Biotech brought the world innovation and cures and helped things get back to the new normal…
Join this panel of the leading investors in digital health to learn more about the 2022 investment…
Economic marginalization can lead to gaps in access to healthcare and education, income disparities…
The last 24 months have exposed business operations to unprecedented supply chain risks. Whether…
In recent times, the epigenetic drug discovery field has made substantial progress. So far,…
4:15 PM - 5:15 PM (PDT)
Scientific breakthroughs during the pandemic are driving a lot of optimism around mRNA technology,…
Women leaders have become increasingly more prominent throughout biotech in recent years, and these…
Creating an equitable and inclusive biotech ecosystem that fosters participation of individuals…
Neurological disorders pose some of the greatest challenges and areas of unmet need in medicine…
The current stock market environment for small biotechs is tough even by historical standards. …
Now, the most critical assets of life sciences companies are data and information. They are virtual…
4:15 PM - 4:45 PM (PDT)
David Thomas, BIO’s Vice President of Industry Analysis, will provide an overview of recent…
Wednesday, June 15
11:00 AM - 12:00 PM (PDT)
There has been tremendous progress in advancing gene therapies and delivering these life-changing…
Vital Transformation will present new research supported by a BIO led consortium which quantifies…
 With a 90% failure rate and tens of billions in lost R&D costs every year, there is no…
The urgency of the COVID-19 pandemic has accelerated the development, trial, and use of innovative…
This panel of leading industry experts will discuss key considerations and experiences related to…
Protein degradation has emerged as one of the hottest areas of therapeutic research. Harnessing the…
Do you have what it takes to entice the industry’s top investors? Bring your A-game as you…
20 years ago, European pharmaceutical legislation underwent a major review, a critical point in the…
A discussion among panelists regarding the role of Big Data and AI at each stage of the drug…
 Prescription Digital Therapeutics (PDTs) present a novel opportunity for companies to develop…
Join some of Pharma’s biggest dealmakers as they discuss the challenges, opportunities, and…
1:45 PM - 2:45 PM (PDT)
Drug development remains a field defined by failure, with roughly 90% of products entering clinical…
The value equation can be very different for patients with various conditions in different…
Diagnostic testing to identify patients who could benefit from targeted therapies is a cornerstone…
Millions of people around the world are impacted by diseases of the brain — including…
Vaccines for COVID-19 were developed, produced and made available in developed countries in less…
Executives can ignite change in the biotechnology ecosystem through strategic funding and company…
Biotech businesspeople who are inexperienced with biosimilars need a plain English explanation of…
The panel will explore the question as to whether crossover rounds are still needed to enter the U…
3:00 PM - 4:00 PM (PDT)
The remarkable convergence of advances in bioengineering and neurology has resulted in a fast…
Over the past decade, the scientific community has delivered an impressive pace of scientific…
Recent successes in genetic medicine (regulatory approvals of Zolgensma and Luxturna, for example)…
Many Life Sciences companies have become ever reliant on global supply chains in order to source…
 Commercial space activity is on the rise with advances in technologies that are lowering…
 In 2021, cancer diagnostics achieved a long-discussed “Holy Grail” milestone with…
  Modern medicine as we know it is threatened by antimicrobial resistance (AMR). From common…
Current value-based arrangements don’t address the stakeholder at the center of the issue …
Traditional drug development has involved fleets of scientists in lab coats.  But with…
4:15 PM - 5:15 PM (PDT)
Developing new therapeutics takes significant time and resources. Even when Federal agencies and…
The identification of novel discoveries – ranging from cutting edge technologies to…
Marwood Group estimates that there are more than 500 CDMOs globally and with more 45 large pharma…
Widespread evidence shows that cognitive problems are the second most commonly reported symptom …
Thursday, June 16
9:00 AM - 10:00 AM (PDT)
 Improvements in care benefit patients but make it harder to demonstrate survival gains in…
 Cellular therapies carry immense promise to provide treatment for previously unmet disease…
Research universities are unparalleled generators of scientific knowledge and potentially impactful…
The psychedelics industry has evolved from a stigmatized counterculture phenomenon to a…
10:15 AM - 11:15 AM (PDT)
During this session, we will provide an overview of the evolving science and AD DMT landscape,…
New federal funding tools to support translational research and bio tech hubs are being developed…
Many life sciences companies offer programs to help patients afford their medications. But how can…
During recent years, a few challenges and risks to patients have been reported emerging from viral…